Early Lapatinib-Induced Skin Rash Predicts Better Survival With Lapatinib+Trastuzumab Therapy - Cancer Therapy Advisor

$ 16.99 · 4.6 (361) · In stock

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

Lapatinib and lapatinib plus trastuzumab therapy versus

Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast

Lapatinib and lapatinib plus trastuzumab therapy versus

Early Lapatinib-Induced Skin Rash Predicts Better Survival With

Risk-based decision-making in the treatment of HER2-positive early

PDF) Efficacy and Safety of Pertuzumab and Trastuzumab

Lapatinib and lapatinib plus trastuzumab therapy versus